Wikidata

(Q43989417)

English

High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention

scientific article

In more languages

Statements

title
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
author name string
Nicoline J Breet
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
Jochem W van Werkum
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
Heleen J Bouman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
Johannes C Kelder
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
Ankie M Harmsze
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
Christian M Hackeng
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
Jurriën M ten Berg
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
publication date
8 April 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017
page(s)
983-990
1 reference
stated in
Europe PubMed Central
PubMed ID
21478385
retrieved
28 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43989417&oldid=2105358187"